Patent · US Active

Anti-neublastin antibodies and uses thereof

US10047150B2 · kind B2 · utility

1Cited by

0References

9Claims

0Family size

Assignee

GLORIANA THERAPEUTICS SARL · CH

Inventors

Anthony Rossomando · Grafton, US
Ping Jin · Ebeye, US

Key dates

Filing date	Jan 5, 2015
Grant date	Aug 14, 2018
Priority date	—
Expiry date	Jan 5, 2035

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07K2317/76
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

Antibodies and antigen binding fragments that bind to neublastin polypeptides are disclosed. Also disclosed are methods of using the antibodies and antigen binding fragments in assays for detecting the presence or amount of endogenous and/or exogenous neublastin in a sample and in methods of antagonizing neublastin bioactivity.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.